Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression

Contributed equally
BMC Cancer201212:370

DOI: 10.1186/1471-2407-12-370

Received: 1 February 2012

Accepted: 22 August 2012

Published: 27 August 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
1 Feb 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Feb 2012 Reviewed Reviewer Report - Laura Gatti
23 Mar 2012 Reviewed Reviewer Report - Wainer Zoli
4 Apr 2012 Reviewed Reviewer Report - Anna Tesei
6 May 2012 Author responded Author comments - Junye Liu
Resubmission - Version 3
6 May 2012 Submitted Manuscript version 3
9 May 2012 Reviewed Reviewer Report - Laura Gatti
21 May 2012 Reviewed Reviewer Report - Wainer Zoli
22 May 2012 Reviewed Reviewer Report - Anna Tesei
26 Jul 2012 Author responded Author comments - Junye Liu
Resubmission - Version 4
26 Jul 2012 Submitted Manuscript version 4
20 Aug 2012 Reviewed Reviewer Report - Laura Gatti
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
22 Aug 2012 Editorially accepted
27 Aug 2012 Article published 10.1186/1471-2407-12-370

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Radiation Medicine, Fourth Military Medical University
(2)
Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University
(3)
Department of Oncology, Xi’an Central Hospital

Advertisement